Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Calcitonin inhibits both osteoclast formation and bone resorption, and is a primary treatment for patients with hypercalcemia and increased bone turnover. However, the clinical utility of calcitonin is limited because patients become refractory to calcitonin after several days (the calcitonin "escap...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	J Clin Invest
Principais autores:	Takahashi, S, Goldring, S, Katz, M, Hilsenbeck, S, Williams, R, Roodman, G D
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Clinical Investigation 1995
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7814611/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117634
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!